Polymorphisms of interleukin (IL)-1α, IL-1β, IL-6, IL-10, and IL-18 and the risk of ovarian cancer

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 672-679

  Bushley, Abigail W ^a   Ferrell, Robert ^a   McDuffie, Katharine ^a   Terada, Keith Y ^a   Carney, Michael E ^a   Thompson, Pamela J ^a   Wilkens, Lynne R ^a   Tung, Ko Hui ^a   Ness, Roberta B ^a   Goodman, Marc T ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Carcinogenesis; Ovarian Cancer; Polymorphism

Indexed keywords

CYTOSINE; GUANINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 6; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; BLOOD SAMPLING; CANCER RISK; CANCER STAGING; CONFIDENCE INTERVAL; CONTRACEPTION; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; EDUCATION; ETHNOLOGY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFORMATION PROCESSING; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK; STATISTICAL SIGNIFICANCE; UNITED STATES; UTERINE TUBE LIGATION;

EID: 9944228282     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.024     Document Type: Article

References (38)

1. American Cancer Society Cancer Facts and Figures 2004 2004 American Cancer Society, Inc.
2. M.F. Fathalla Incessant ovulation-A factor in ovarian neoplasia? Lancet 2 7716 1971 163
3. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone JNCI 90 23 1998 1774 1786
4. R.B. Ness, J.A. Grisso, C. Cottreau, J. Klapper, R. Vergona, and J.E. Wheeler Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer Epidemiology 11 2000 111 117
5. R.B. Ness, M.T. Goodman, C. Shen, and R.C. Brunham Serologic evidence of past infection with Chlamydia trachomatis in relation to ovarian cancer J. Infect. Dis. 187 2003 1147 1152
6. K.L. Irwin, N.S. Weiss, N.C. Lee, and H.B. Peterson Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer Am. J. Epidemiol. 134 1991 362 369
7. K.-H. Tung, M.T. Goodman, A.H. Wu, K. McDuffie, L.R. Wilkens, and L.N. Kolonel Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study Am. J. Epidemiol. 158 2003 629 638
8. M.T. Goodman, K. McDuffie, L.N. Kolonel, K. Terada, T.A. Donlon, and L.R. Wilkens Multiethnic case-control study of ovarian cancer and polymorphisms in genes involved in catechol estrogen formation and metabolism Cancer Epidemiol. Biomark Prev. 10 2001 209 216
9. M.T. Goodman, A.H. Wu, K.-H. Tung, K. McDuffie, L.N. Kolonel, and A.M. Nomura The association of dairy products, lactose, and calcium with the risk of ovarian cancer Am. J. Epidemiol. 156 2002 148 157
10. E.M. Shambaugh M.A. Weiss SEER Summary Staging Guide 1977 National Cancer Institute Bethesda
11. R.E. Scully, and L.H. Sobin Histological Typing of Ovarian Tumours 1999 Springer Berlin, NY
12. K.J. Livak SNP genotyping by the 5′-nuclease reaction Methods Mol. Biol. 212 2003 129 147
13. D. Hosmer, and S. Lemeshow Applied Logistic Regression 1989 Wiley New York
14. E. El-Omar, M. Carrington, W.-H. Chow, K.E. McColl, J.H. Bream, and H.A. Young Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 2000 398 402
15. N. Hamajima, K. Matsuo, T. Saito, K. Tajima, K. Okuma, and K. Yamao Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection Jpn. J. Cancer Res. 92 2001 383 389
16. P.L. McGeer, and E.G. McGeer Poymorphisms in inflammatory genes and the risk of Alzheimer disease Arch. Neurol. 58 2001 1790 1792
17. A. Cantagrel, F. Navauz, Loubet-Lescoulie, F. Nourhashemi, G. Enault, and M. Abbal Interleukin-1B, interleukin-1 receptor antagonist, interleukin-4 and interleukin-10 gene polymorphisms Arthritis Rheum. 42 6 1999 1093 1100
18. C.D. Woodworth, E. McMullin, M. Iglesias, and G.D. Plowman Interleukin 1a and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells Proc. Natl. Acad. Sci. 92 1995 2840 2844
19. C. Marth, A.G. Zeimet, M. Herold, C. Brumm, G. Windbichler, and E. Muller-Holzner Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells Int. J. Cancer 67 1996 826 830
20. L.A. Hefler, E. Ludwig, A. Lebrecht, R. Zeillinger, D. Tong-Cacsire, and H. Koelbl Polymorphisms of the interleukin-1 gene cluster and ovarian cancer J. Soc. Gynecol. Invest. 9 6 2002 386 390
21. M.Y. Tjiong, N. van der Vange, F.J. ten Kate, S.P. Tjong-A-Hung, J. ter Schegget, and M.P. Burger Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer Gynecol. Oncol. 73 1999 285 291
22. E. Darai, R. Detchev, D. Hugol, and N.T. Quang Serum and cyst fluid levels of interleukin(IL) -6, IL-8 and tumor necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumors Hum. Reprod. 18 8 2003 1681 1685
23. L.A. Hefler, C. Grimm, Ackermann, S. Malur, A.R. Radjabi-Rahat, and S. Leodolter An interleukin-6 polymorphism influences the biological phenotype of ovarian cancer Cancer Res. 63 12 2003 3066 3068
24. E. Alamartine, P. Berthouz, C. Mariat, F. Cambazard, and B. Bethoux Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation J. Invest. Dermatol. 120 1 2003 99 103
25. T. Kohno, H. Mizukami, M. Suzuki, Y. Saga, Y. Takei, and M. Shimpo Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer Cancer Res. 63 2003 5091 5094
26. S.-J. Lee, Y.-S. Cho, M.-C. Cho, J.H. Shim, K.A. Lee, and K.K. Ko Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced INF-g production in human peripheral blood mononuclear and NK cells J. Immunol. 167 2001 497 504
27. C.A. Dinarello Interleukin-18 Methods 19 1999 121 132
28. T. Osaki, J.-M. Peron, Q. Cai, H. Okamura, P.D. Robbins, and M. Kurimoto INF-gamma-inducing factor/IL-18 administration mediates IFN-gamma and IL-12-independent antitumor effects J. Immunol. 160 1998 1742 1749
29. Z.Y. Wang, A. Gaggero, A. Rubartelli, O. Rosso, S. Miotti, and D. Mezzanzanica Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells Int. J. Cancer 98 2002 873 878
30. M.A. Nash, R. Lenzi, C.L. Edwards, J.J. Kavanagh, A.P. Kudelka, and C.F. Verschraegen Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines Clin. Exp. Immunol. 112 1998 172 180
31. G.H. Windbichler, H. Hausmaninger, W. Stummvoll, A.H. Graf, C. Kainz, and J. Lahodny Interferon-gamma in the first line therapy of ovarian cancer: a randomized phase II trial Br. J. Cancer 82 2000 1138 1144
32. E.M. Hartenbach, T.A. Olson, J.J. Goswitz, D. Mohanraj, L.B. Twiggs, and L.F. Carson Vascular endothelial growth factor expression and survival in human epithelial ovarian carcinomas Cancer Lett. 121 1997 169 175
33. J. Akahiro, R. Konno, K. Ito, K. Okamura, and N. Yaegashi Impact of serum interleukin-18 level as a prognostic indicator in patients with epithelial ovarian carcinoma Int. J. Clin. Oncol. 9 2004 42 46
34. T. Kawabata, T. Ichikura, T. Majima, S. Seki, K. Chochi, and E. Takayama Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma Cancer 92 2001 2050 2055
35. P. Lissoni, F. Brivio, F. Rovelli, G. Fumagalli, F. Malugani, and M. Vaghi Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease J. Biol. Regul. Homeostatic Agents 14 2000 275 277
36. F. Vidal-Vanaclocha, G. Fantuzzi, L. Mendoza, A.M. Fuentes, M.J. Anasagasti, and J. Martin IL-18 regulates IL-1-beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1 Proc. Natl. Acad. Sci. 97 2000 734 739
37. M.T. Carrascal, L. Mendoza, M. Valcarel, C. Salado, E. Egilegor, and N. Telleria Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium Cancer Res. 63 2003 491 497
38. V. Giedraitis, B. He, W.X. Huang, and J. Hillert Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation J. Neuroimmunol. 112 2001 126 152